fig3

Cancer stem cells in cholangiocarcinoma: emerging roles as therapeutic targets

Figure 3. The hierarchy of cholangiocarcinoma stem cells. Hepatic progenitor/stem cells differentiate into hepatocytes and cholangiocytes. Through carcinogenesis involving various factors, these cells can develop into HCC and CCA, respectively. Moreover, hepatic progenitor/stem cells with genetic abnormalities can reprogram into CCA-CSCs or HCC cells. These abnormal cells then proliferate and differentiate to form CCA and HCC cells. Additionally, hepatocytes can act as stem-like cells in the liver and possess the ability to reprogram into CCA-CSCs, suggesting that mature hepatocytes may serve as an origin of CCA through genetic and epigenetic alterations, as well as influences from the microenvironment. CSC: Cancer stem cell; CCA: cholangiocarcinoma; HCC: hepatocellular carcinoma.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/